Witte, K., Schnecko, A., Schmidt, T., Voll, C., Kränzlin, B., & Lemmer, B. (1999). Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats. General pharmacology, 33(5), . https://doi.org/10.1016/S0306-3623(99)00037-3
Chicago-Zitierstil (17. Ausg.)Witte, Klaus, Anke Schnecko, T. Schmidt, Christian Voll, Bettina Kränzlin, und Björn Lemmer. "Cardiovascular Risk, Renal Hypertensive Damage, and Effects of Amlodipine Treatment in Transgenic TGR(mREN2)27 Rats." General Pharmacology 33, no. 5 (1999). https://doi.org/10.1016/S0306-3623(99)00037-3.
MLA-Zitierstil (9. Ausg.)Witte, Klaus, et al. "Cardiovascular Risk, Renal Hypertensive Damage, and Effects of Amlodipine Treatment in Transgenic TGR(mREN2)27 Rats." General Pharmacology, vol. 33, no. 5, 1999, https://doi.org/10.1016/S0306-3623(99)00037-3.